RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (FRX:CA), a commercial stage specialty pharmaceutical company, today announced that the U.S. Food and Drug ...
The US Food and Drug Administration (FDA) has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals) injection to reduce the risk for ototoxicity associated with cisplatin in pediatric patients ...
~ PEDMARK is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients ~ “We are proud to announce that PEDMARK is now available to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results